Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.

Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one ...

Fulgent Genetics ( ($FLGT) ) has shared an update. On December 20, 2025, Fulgent Genetics’ subsidiary Inform Diagnostics signed agreements to buy ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services ...

Approaches incorporating rapid or digital PCR, CRISPR, syndromic testing, and multimodal systems reached new milestones this year.

Roche’s cobas liat Bordetella test earns FDA clearance, delivering accurate whooping cough results in 15 minutes.

Precise tumor diagnosis and treatment require the support of abundant molecular information. However, conventional molecular ...

Gorakhpur: Conventional smear microscopy, though widely used in India, misses detection of many tuberculosis (TB) cases, ...

He complained that KP was not receiving its constitutionally-mandated financial share in full and that the province’s dues to ...

In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...

The world of medical testing is always changing, and point-of-care molecular diagnostics are a big part of that. These tests let us find out what’s going on with a patient’s health right there, ...

Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform ...